Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.
Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis.
Evaluation of serum oxidant/antioxidant balance in multiple sclerosis.
Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system.
Amelioration of experimental autoimmune encephalomyelitis by anatabine.
Preventive healthcare use among males with multiple sclerosis.
Lack of response to pulse cyclophosphamide in neuromyelitis optica: evaluation of 7 patients.
Multiple sclerosis and pain.
Fingolimod for multiple sclerosis: a review for the specialist nurse.
Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis.
The genetics of multiple sclerosis: an up-to-date review.
Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study.
Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis.
The refinement of genetic predictors of multiple sclerosis.
Quantitative Evaluation of BAFF, HMGB1, TLR 4 AND TLR 7 Expression in Patients with Relapsing Remitting Multiple Sclerosis.
Peripheral blood T cell dynamics predict relapse in multiple sclerosis patients on fingolimod.
Distribution of JC polyomavirus genotypes in Tunisian renal transplant recipients between January 2008 and January 2011.
PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation.
Accuracy of StepWatch™ and ActiGraph Accelerometers for Measuring Steps Taken among Persons with Multiple Sclerosis.
Extracellular O-linked β-N-acetylglucosamine: Its biology and relationship to human disease.
In vivo vs. ex vivo Magnetic Resonance Imaging In Mice.
Immune reconstitution inflammatory syndrome in a patient treated with natalizumab presenting progressive multifocal leukoencephalopathy.
Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain.
"Bright spotty lesions" on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis.
Optic Neuritis Probably Induced by Isotretinoin.
Pages
« first
‹ previous
…
155
156
157
158
159
160
161
162
163
…
next ›
last »